- Home
- BMRN vs CAG Comparison
BMRN vs CAG Comparison
Compare BMRN & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- CAG
- Stock Information
- Founded
- BMRN 1996
- CAG 1919
- Country
- BMRN United States
- CAG United States
- Employees
- BMRN N/A
- CAG N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- CAG Packaged Foods
- Sector
- BMRN Health Care
- CAG Consumer Staples
- Exchange
- BMRN Nasdaq
- CAG Nasdaq
- Market Cap
- BMRN 12.1B
- CAG 9.7B
- IPO Year
- BMRN 1999
- CAG N/A
- Fundamental
- Price
- BMRN $59.01
- CAG $19.22
- Analyst Decision
- BMRN Buy
- CAG Hold
- Analyst Count
- BMRN 23
- CAG 10
- Target Price
- BMRN $93.73
- CAG $21.90
- AVG Volume (30 Days)
- BMRN 1.8M
- CAG 11.9M
- Earning Date
- BMRN 08-04-2025
- CAG 07-10-2025
- Dividend Yield
- BMRN N/A
- CAG 7.29%
- EPS Growth
- BMRN 152.82
- CAG 233.33
- EPS
- BMRN 2.71
- CAG 2.40
- Revenue
- BMRN $2,950,227,000.00
- CAG $11,612,800,000.00
- Revenue This Year
- BMRN $12.27
- CAG $0.45
- Revenue Next Year
- BMRN $9.99
- CAG N/A
- P/E Ratio
- BMRN $21.81
- CAG $8.00
- Revenue Growth
- BMRN 19.36
- CAG N/A
- 52 Week Low
- BMRN $52.93
- CAG $18.67
- 52 Week High
- BMRN $94.85
- CAG $33.24
- Technical
- Relative Strength Index (RSI)
- BMRN 55.66
- CAG 35.83
- Support Level
- BMRN $56.48
- CAG $18.67
- Resistance Level
- BMRN $60.43
- CAG $19.88
- Average True Range (ATR)
- BMRN 1.52
- CAG 0.54
- MACD
- BMRN 0.23
- CAG 0.07
- Stochastic Oscillator
- BMRN 64.05
- CAG 25.35
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (over 90% of fiscal 2024 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. The company primarily sells through the US retail channel, with just 9% of fiscal 2024 revenue coming from international markets and 10% from foodservice.